Advancing evidence-generating medicine
Osmind’s research is helping to set new standards for mental health interventions and improve patient outcomes. See how we work with research partners to generate real-world evidence to accelerate advances in mental health care.
Selected research projects
A Retrospective Analysis of Ketamine Intravenous Therapy for PTSD in Real-World Care Settings
McInnes, L. A., Berman, R. M., Worley, M. J., & Shih, E. (2024), American College of Neuropsychopharmacology
Examining the Factor Structure of the Transdiagnostic DSM-5-TR Level 1 Cross-Cutting Symptom Measure in Real World Psychiatric Outpatients
MacMillan, C., Shih, E., Worley, M., Kane, G., Qian, J., McInnes, L. A., Gogtay, N., & Gibson, D. (2024), American College of Neuropsychopharmocology
Leveraging a Learning Health System to Implement the DSM-5-TR Level 1 Cross-Cutting Measure
MacMillan, C., Qian, J., McInnes, L. A., Worley, M., Muir, O., Gogtay, N., & Gibson, D. (2024), CNS Summit
Osmind and UBC partner to Advance Mental Health Treatment Through REMS Innovation
Bridging research and clinical care in a new era of psychiatry
McInnes and Qian (2024). Fierce Pharma.
Osmind Welcomes Dr. Robert M. Berman, M.D. as Strategic Advisor
Let's transform mental health together
Click here to learn more about our research or to discuss collaboration opportunities.
